[go: up one dir, main page]

EE200300398A - Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon - Google Patents

Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon

Info

Publication number
EE200300398A
EE200300398A EEP200300398A EEP200300398A EE200300398A EE 200300398 A EE200300398 A EE 200300398A EE P200300398 A EEP200300398 A EE P200300398A EE P200300398 A EEP200300398 A EE P200300398A EE 200300398 A EE200300398 A EE 200300398A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
composition containing
isoxazoline derivative
medicament
Prior art date
Application number
EEP200300398A
Other languages
English (en)
Inventor
Ignacio Andr�s-Gil Jos�
Javier Fernndez-Gadea Francisco
Jes�s Alc�zar-Vaca Manuel
Maria Cid-Nu�ez Jos�
Pastor-Fernandez Joaquin
Adrianus Hendrikus Petrus Megens Antonius
Irma Christine Maria Heylen Godelieve
Jean Michel Langlois Xavier
Henrica Maria Bakker Margaretha
Horst Wolfgang Steckler Thomas
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200300398A publication Critical patent/EE200300398A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EEP200300398A 2001-02-21 2002-02-13 Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon EE200300398A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05
PCT/EP2002/001567 WO2002066484A1 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants

Publications (1)

Publication Number Publication Date
EE200300398A true EE200300398A (et) 2003-12-15

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300398A EE200300398A (et) 2001-02-21 2002-02-13 Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon

Country Status (32)

Country Link
US (1) US7169786B2 (et)
EP (1) EP1368358B1 (et)
JP (1) JP3953424B2 (et)
KR (1) KR100848898B1 (et)
CN (1) CN100400540C (et)
AR (1) AR035685A1 (et)
AT (1) ATE337322T1 (et)
AU (1) AU2002244717B2 (et)
BG (1) BG107984A (et)
BR (1) BR0207433A (et)
CA (1) CA2437505C (et)
CY (1) CY1106448T1 (et)
CZ (1) CZ20032515A3 (et)
DE (1) DE60214138T2 (et)
DK (1) DK1368358T3 (et)
EA (1) EA006747B1 (et)
EE (1) EE200300398A (et)
EG (1) EG23929A (et)
ES (1) ES2271230T3 (et)
HR (1) HRP20030647A2 (et)
HU (1) HUP0303270A3 (et)
IL (2) IL157470A0 (et)
MX (1) MXPA03007432A (et)
MY (1) MY137836A (et)
NO (1) NO20033700L (et)
NZ (1) NZ526741A (et)
PL (1) PL208593B1 (et)
PT (1) PT1368358E (et)
SI (1) SI1368358T1 (et)
SK (1) SK11612003A3 (et)
TW (1) TWI257392B (et)
WO (1) WO2002066484A1 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
IL164341A0 (en) * 2002-04-02 2005-12-18 Janssen Pharmaceutica Nv Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
JP4478571B2 (ja) * 2002-08-15 2010-06-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 縮合複素環式イソオキサゾリン誘導体及び抗うつ薬としてのそれらの使用
MY134287A (en) 2002-08-21 2007-11-30 Janssen Pharmaceutica Nv C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
KR20050114641A (ko) * 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
AU2004283196B2 (en) 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
DE602005016836D1 (de) 2004-11-26 2009-11-05 Janssen Pharmaceutica Nv Chotischer und anxiolytischer aktivität
MY147757A (en) 2007-03-09 2013-01-15 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
US7863266B2 (en) * 2007-06-08 2011-01-04 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2055011T3 (es) * 1988-09-19 1994-08-16 Akzo Nv Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
ES2182064T3 (es) * 1996-04-12 2003-03-01 Janssen Pharmaceutica Nv Derivados de isoxazolidina.
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
DE69914931T2 (de) * 1998-10-09 2004-12-16 Janssen Pharmaceutica N.V. 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung

Also Published As

Publication number Publication date
CN1492871A (zh) 2004-04-28
EG23929A (en) 2008-01-14
EP1368358A1 (en) 2003-12-10
KR20030076590A (ko) 2003-09-26
US20040122037A1 (en) 2004-06-24
DK1368358T3 (da) 2007-01-02
EP1368358B1 (en) 2006-08-23
JP3953424B2 (ja) 2007-08-08
EA200300915A1 (ru) 2004-06-24
HUP0303270A2 (hu) 2004-01-28
EA006747B1 (ru) 2006-04-28
MY137836A (en) 2009-03-31
CY1106448T1 (el) 2011-10-12
PT1368358E (pt) 2007-01-31
KR100848898B1 (ko) 2008-07-29
CN100400540C (zh) 2008-07-09
SK11612003A3 (sk) 2004-04-06
SI1368358T1 (sl) 2007-02-28
JP2004518748A (ja) 2004-06-24
IL157470A (en) 2008-07-08
PL208593B1 (pl) 2011-05-31
ES2271230T3 (es) 2007-04-16
HUP0303270A3 (en) 2007-03-28
DE60214138T2 (de) 2007-03-29
CZ20032515A3 (cs) 2003-12-17
DE60214138D1 (de) 2006-10-05
BG107984A (bg) 2004-09-30
NO20033700D0 (no) 2003-08-20
TWI257392B (en) 2006-07-01
MXPA03007432A (es) 2003-11-18
WO2002066484A1 (en) 2002-08-29
IL157470A0 (en) 2004-03-28
NZ526741A (en) 2004-04-30
HK1065537A1 (zh) 2005-02-25
PL363264A1 (en) 2004-11-15
ATE337322T1 (de) 2006-09-15
CA2437505C (en) 2010-02-09
BR0207433A (pt) 2004-06-01
AU2002244717B2 (en) 2007-07-19
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29
US7169786B2 (en) 2007-01-30
NO20033700L (no) 2003-10-21
HRP20030647A2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE05404B1 (et) Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette n„htud respiratoorsete, kuseelundite v?i mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
EE200300295A (et) Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
EE05475B1 (et) Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
EE200300240A (et) Arüülitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE05082B1 (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE200200498A (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksadiasol-2-oon, selle valmistamine ja kasutamine hormoontundlikku lipaasi pärssivas ravimis ning seda sisaldav suhkurtõve ravim
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
EE200200617A (et) (Tio)karbamiidi derivaat, seda sisaldav farmatseutiline preparaat, selle valmistamine ning kasutamine VIIa-teguri inhibiitorina
EE200100096A (et) Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
EE200200057A (et) Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
NO20035581D0 (no) Farmasöytisk formulering med maskert smak samt fremstilling derav
EE200200493A (et) Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE04855B1 (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine